Cargando…

De-escalation of Broad Spectrum Antibiotics Following Negative Cultures in Pneumonia: Rates and Outcomes

BACKGROUND: For patients at risk for multidrug resistant organisms, IDSA/ATS guidelines recommend empiric therapy with 1 agent against methicillin-resistant Staphylococcus aureus (MRSA) and another against Pseudomonas. Following negative cultures, guidelines are unclear regarding antibiotic de-escal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deshpande, Abhishek, Richter, Sandra S, Haessler, Sarah, Brizendine, Kyle, Lindenauer, Peter, Yu, Pei-Chun, Zilberberg, Marya D, Imrey, Peter, Higgins, Thomas, Rothberg, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631249/ http://dx.doi.org/10.1093/ofid/ofx163.1284

Ejemplares similares

Assessment of the Accuracy of Using ICD-9 Diagnosis Codes to Identify Pneumonia Etiology in Patients Hospitalized With Pneumonia
por: Higgins, Thomas L., et al.
Publicado: (2020)

2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
por: Bartley, Patricia, et al.
Publicado: (2019)

2794. Testing and Treatment in Patients Hospitalized with Suspected Influenza Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

1457. Escherichia coli Community Acquired Pneumonia
por: John, Teny Mathew, et al.
Publicado: (2018)

1501. Risk Factors for Clostridium difficile Infection in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia
por: Gupta, Niyati M., et al.
Publicado: (2019)

1469. Microbial Etiology of Community-Acquired Pneumonia Requiring Hospitalization Among US Adults
por: Deshpande, Abhishek, et al.
Publicado: (2018)

A risk model to identify Legionella among patients admitted with community‐acquired pneumonia: A retrospective cohort study
por: Rothberg, Michael B., et al.
Publicado: (2022)

879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022)

Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021)

Using Highly Detailed Administrative Data to Predict Pneumonia Mortality
por: Rothberg, Michael B., et al.
Publicado: (2014)

2206. Patterns of Care and Outcomes in Elderly Patients Hospitalized with Community-acquired Pneumonia in the United States
por: Rastogi, Radhika, et al.
Publicado: (2019)

869. Evaluation of Broad-Spectrum Antibiotic De-Escalation in Patients with Health-Care Associated Pneumonia (HCAP) and No Microbiological Diagnosis
por: Patel, Twisha S, et al.
Publicado: (2018)

Broad-Spectrum Antibiotic Use at Choice, Change, and Completion Throughout VA: Patterns of Initiation and De-escalation
por: Goetz, Matthew, et al.
Publicado: (2017)

De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia
por: Rearigh, Lindsey, et al.
Publicado: (2020)

Continuation Versus De-escalation of Broad-Spectrum Antibiotic Therapy in Critically Ill COVID-19 Patients
por: Aldardeer, Namareq F., et al.
Publicado: (2023)

1319. Assessment of Spectrum Score-Based Antibiotic De-Escalation in Patients with Nosocomial Pneumonia
por: Ilges, Daniel T, et al.
Publicado: (2021)

Effect of Broad-Spectrum Antibiotic De-escalation on Critically Ill Patient Outcomes: A Retrospective Cohort Study
por: Aldardeer, Namareq, et al.
Publicado: (2023)

2688. The Clinical Impact of Early De-escalation of Broad-Spectrum Antibiotics in Acute Myeloid Leukemia Patients with Febrile Neutropenia
por: Davis, Matthew, et al.
Publicado: (2019)

574. De-escalation of Broad Spectrum Antibiotics during Cytokine Release Syndrome with Haploidentical Hematopoietic Stem Cell Transplantation
por: Schiffer, Molly, et al.
Publicado: (2020)

Designer broad-spectrum polyimidazolium antibiotics
por: Zhong, Wenbin, et al.
Publicado: (2020)

Comparative analysis of the effectiveness of narrow-spectrum versus broad-spectrum antibiotics for the treatment of childhood pneumonia
por: Demeke, Chilot Abiyu, et al.
Publicado: (2021)

2666. De-escalation of Broad-Spectrum Antibiotics in Hematopoietic Stem Cell Transplant Patients During Initial Episode of Febrile Neutropenia
por: Rearigh, Lindsey, et al.
Publicado: (2019)

Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia
por: Schlueter, M., et al.
Publicado: (2010)

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
por: Khasawneh, Faisal A, et al.
Publicado: (2014)

1484. Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Deshpande, Abhishek, et al.
Publicado: (2020)

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Assessment of Antibiotic De-escalation by Spectrum Score in Patients With Nosocomial Pneumonia: A Single-Center, Retrospective Cohort Study
por: Ilges, Dan, et al.
Publicado: (2021)

Comparison of broad-spectrum antibiotics and narrow-spectrum antibiotics in the treatment of lower extremity cellulitis
por: Almulhim, Abdulaziz Saleh, et al.
Publicado: (2018)

Factors associated with the appropriate use of ultra-broad spectrum antibiotics, meropenem, for suspected healthcare-associated pneumonia
por: Kirsch, Nathan, et al.
Publicado: (2021)

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

Characteristics of doripenem: a new broad-spectrum antibiotic
por: Alvarez-Lerma, Francisco, et al.
Publicado: (2009)

In the era of broad spectrum antibiotics, is ampicillin still an option?
por: Popescu, Cristina, et al.
Publicado: (2013)

Less empiric broad-spectrum antibiotics is more in the ICU
por: da Fonseca Pestana Ribeiro, Jose Mauro, et al.
Publicado: (2019)

2281 Prophylactic broad-spectrum antibiotics for childhood malnutrition
por: Langdon, Amy Elizabeth, et al.
Publicado: (2018)

JMM Profile: Carbapenems: a broad-spectrum antibiotic
por: Armstrong, Tom, et al.
Publicado: (2021)

Broad spectrum antibiotic stewardship by quality improvement methods
por: Niazi-Ali, Saarah, et al.
Publicado: (2022)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
por: Álvarez-Lerma, Francisco, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_omvoeli63jr3ttqvi75tvka6te